CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing

被引:789
|
作者
Montague, Tessa G. [1 ]
Cruz, Jose M. [2 ,3 ]
Gagnon, James A. [1 ]
Church, George M. [3 ,4 ]
Valen, Eivind [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[2] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA
[3] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA
[4] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
关键词
HUMAN-CELLS; CRISPR-CAS9; SYSTEM; XENOPUS-TROPICALIS; CAS9; NUCLEASE; DESIGN TOOL; SPECIFICITY; MUTAGENESIS; DROSOPHILA; EFFECTORS; GENES;
D O I
10.1093/nar/gku410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Major advances in genome editing have recently been made possible with the development of the TALEN and CRISPR/Cas9 methods. The speed and ease of implementing these technologies has led to an explosion of mutant and transgenic organisms. A rate-limiting step in efficiently applying TALEN and CRISPR/Cas9 methods is the selection and design of targeting constructs. We have developed an online tool, CHOPCHOP (https://chopchop.rc.fas.harvard.edu), to expedite the design process. CHOPCHOP accepts a wide range of inputs (gene identifiers, genomic regions or pasted sequences) and provides an array of advanced options for target selection. It uses efficient sequence alignment algorithms to minimize search times, and rigorously predicts off-target binding of single-guide RNAs (sgRNAs) and TALENs. Each query produces an interactive visualization of the gene with candidate target sites displayed at their genomic positions and color-coded according to quality scores. In addition, for each possible target site, restriction sites and primer candidates are visualized, facilitating a streamlined pipeline of mutant generation and validation. The ease-of-use and speed of CHOPCHOP make it a valuable tool for genome engineering.
引用
收藏
页码:W401 / W407
页数:7
相关论文
共 50 条
  • [21] Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
    Katigbak, Alexandra
    Robert, Francis
    Paquet, Marilene
    Pelletier, Jerry
    G3-GENES GENOMES GENETICS, 2018, 8 (05): : 1627 - 1635
  • [22] Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing
    Chadwick, Alexandra C.
    Musunuru, Kiran
    CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (07)
  • [23] Genome modification by CRISPR/Cas9
    Ma, Yuanwu
    Zhang, Lianfeng
    Huang, Xingxu
    FEBS JOURNAL, 2014, 281 (23) : 5186 - 5193
  • [24] CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment
    Akram, Fatima
    ul Haq, Ikram
    Sahreen, Sania
    Nasir, Narmeen
    Naseem, Waqas
    Imitaz, Memoona
    Aqeel, Amna
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [25] CRISPR/CAS9 GENOME EDITING FOR NEURODEGENERATIVE DISEASES
    Nojadeh, Jafar Nouri
    Eryilmaz, Nur Seren Bildiren
    Erguder, Berrin Imge
    EXCLI JOURNAL, 2023, 22 : 567 - 582
  • [26] CRISPR/CAS9, the king of genome editing tools
    A. V. Bannikov
    A. V. Lavrov
    Molecular Biology, 2017, 51 : 514 - 525
  • [27] CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
    Song, Runjie
    Zhai, Qing
    Sun, Lu
    Huang, Enxia
    Zhang, Yu
    Zhu, Yanli
    Guo, Qingyun
    Tian, Yanan
    Zhao, Baoyu
    Lu, Hao
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (17) : 6919 - 6932
  • [28] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [29] CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
    Cheng, Hao
    Zhang, Feng
    Ding, Yang
    PHARMACEUTICS, 2021, 13 (10)
  • [30] The CRISPR/Cas9 Genome Editing Methodology as a Weapon Against Human Viruses
    White, Martyn K.
    Hu, Wenhui
    Khalili, Kamel
    DISCOVERY MEDICINE, 2015, 19 (105) : 255 - 262